Alnylam Pharmaceuticals
ALNY
#1148
Rank
$20.31 B
Marketcap
$151.64
Share price
-3.17%
Change (1 day)
-65.67%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company